Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The first GLP-1 receptor agonist approved by the FDA was exenatide, which received approval in April 2005 for the treatment of type 2 diabetes
Current guidelines advise discontinuation before conception due to unknown teratogenic risks
Check the Pharmacy 3
If you are not a good candidate for GLP-1 agonists, our providers will offer different modalities of weight loss for you, including alternative medications, lifestyle modification, continuous glucose monitoring, and other tools
Large outcome trials like SUSTAIN-6 [15] and EXSCEL [19] reported no significant reductions in HF-related hospitalizations
US$ 27.38
US$ 26.34
US$ 20.22
US$ 25.28
US$ 22.47
US$ 20.76
US$ 20.45
US$ 20.61
